BACKGROUND: Abnormalities in language processing and the related brain structures have been reported in people with schizophrenia. It has been proposed that the brain pathways for language processing are anomalous in these individuals and form the underlying basis for the positive symptoms of the illness. If language pathway abnormalities can be detected early in people at high-risk for schizophrenia prior to the onset of symptoms, early treatment can ensue. METHODS: Fifteen young adults at high genetic risk for developing schizophrenia were compared with 15 of their siblings with schizophrenia or schizoaffective disorder and 15 age and sex matched individuals at low risk for schizophrenia using a visual lexical decision task during fMRI. The data were analyzed by contrasting activation obtained during a real word-pseudoword discrimination task to activation obtained during a nonlinguistic discrimination task, and the differential activations were examined. RESULTS: Patterns of brain activation while reading and discriminating between real and pseudowords differed across groups, with more bilateral activation in schizophrenia patients and their high-risk siblings than controls. In control subjects discrimination of words from psuedowords significantly activated Brodmann's area 44 more strongly than when non-linguistic symbols were discriminated. However, high-risk subjects and their siblings with schizophrenia activated this region similarly for both language and non-language tasks. CONCLUSIONS: Normal individuals can be distinguished from subjects at high genetic risk for schizophrenia and patients with schizophrenia by their more lateralized and stronger activation of Brodmann's area 44 to word compared with symbol discrimination tasks. Thus, evaluation of language processing by fMRI may be a valuable tool for use in the prediction of individual risk for developing schizophrenia.
BACKGROUND: Abnormalities in language processing and the related brain structures have been reported in people with schizophrenia. It has been proposed that the brain pathways for language processing are anomalous in these individuals and form the underlying basis for the positive symptoms of the illness. If language pathway abnormalities can be detected early in people at high-risk for schizophrenia prior to the onset of symptoms, early treatment can ensue. METHODS: Fifteen young adults at high genetic risk for developing schizophrenia were compared with 15 of their siblings with schizophrenia or schizoaffective disorder and 15 age and sex matched individuals at low risk for schizophrenia using a visual lexical decision task during fMRI. The data were analyzed by contrasting activation obtained during a real word-pseudoword discrimination task to activation obtained during a nonlinguistic discrimination task, and the differential activations were examined. RESULTS: Patterns of brain activation while reading and discriminating between real and pseudowords differed across groups, with more bilateral activation in schizophreniapatients and their high-risk siblings than controls. In control subjects discrimination of words from psuedowords significantly activated Brodmann's area 44 more strongly than when non-linguistic symbols were discriminated. However, high-risk subjects and their siblings with schizophrenia activated this region similarly for both language and non-language tasks. CONCLUSIONS: Normal individuals can be distinguished from subjects at high genetic risk for schizophrenia and patients with schizophrenia by their more lateralized and stronger activation of Brodmann's area 44 to word compared with symbol discrimination tasks. Thus, evaluation of language processing by fMRI may be a valuable tool for use in the prediction of individual risk for developing schizophrenia.
Authors: Mark W Woolrich; Timothy E J Behrens; Christian F Beckmann; Mark Jenkinson; Stephen M Smith Journal: Neuroimage Date: 2004-04 Impact factor: 6.556
Authors: Heidi W Thermenos; Larry J Seidman; Hans Breiter; Jill M Goldstein; Julie M Goodman; Russell Poldrack; Stephen V Faraone; Ming T Tsuang Journal: Biol Psychiatry Date: 2004-03-01 Impact factor: 13.382
Authors: Ute Habel; Martina Klein; N Jon Shah; Ivan Toni; Karl Zilles; Peter Falkai; Frank Schneider Journal: Am J Psychiatry Date: 2004-10 Impact factor: 18.112
Authors: J I Nurnberger; M C Blehar; C A Kaufmann; C York-Cooler; S G Simpson; J Harkavy-Friedman; J B Severe; D Malaspina; T Reich Journal: Arch Gen Psychiatry Date: 1994-11
Authors: L E DeLisi; A M Boccio; H Riordan; A L Hoff; A Dorfman; J McClelland; M Kushner; O Van Eyl; N Oden Journal: Psychiatry Res Date: 1991-07 Impact factor: 3.222
Authors: H C Whalley; E Simonotto; S Flett; I Marshall; K P Ebmeier; D G C Owens; N H Goddard; E C Johnstone; S M Lawrie Journal: Brain Date: 2004-01-28 Impact factor: 13.501
Authors: Axel Krug; Valentin Markov; Sören Krach; Andreas Jansen; Klaus Zerres; Thomas Eggermann; Tony Stöcker; N Jon Shah; Markus M Nöthen; Alexander Georgi; Jana Strohmaier; Marcella Rietschel; Tilo Kircher Journal: Hum Brain Mapp Date: 2011-01 Impact factor: 5.038
Authors: H W Thermenos; S Whitfield-Gabrieli; L J Seidman; G Kuperberg; R J Juelich; S Divatia; C Riley; G A Jabbar; M E Shenton; M Kubicki; T Manschreck; M S Keshavan; L E DeLisi Journal: Schizophr Res Date: 2013-10-28 Impact factor: 4.939
Authors: Hidayet E Arat; Virginie-Anne Chouinard; Bruce M Cohen; Kathryn E Lewandowski; Dost Öngür Journal: Schizophr Res Date: 2014-12-24 Impact factor: 4.939
Authors: M Kubicki; M E Shenton; P K Maciejewski; P E Pelavin; K J Hawley; T Ballinger; T Swisher; G A Jabbar; H W Thermenos; M S Keshavan; L J Seidman; L E Delisi Journal: Schizophr Res Date: 2013-06-22 Impact factor: 4.939
Authors: Lee Friedman; Jessica A Turner; Hal Stern; Daniel H Mathalon; Liv C Trondsen; Steven G Potkin Journal: Neuroimage Date: 2008-01-05 Impact factor: 6.556